Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.47 |
| ▸ | CTSC | P53634 | 5/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | PRCP | P42785 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | TLR2 | O60603 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34461082 | 1.00 | DPP7 (0.47) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL8526747 | 1.00 | DPP7 (0.47) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL16469461 | 1.00 | DPP7 (0.47) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| Hydrochloric Acid SCHEMBL17222183 | 0.98 | DPP7 (0.46) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL31023074 | 0.94 | DPP7 (0.43) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL30356632 | 0.90 | DPP7 (0.42) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL30729221 | 0.89 | DPP7 (0.48) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL30729269 | 0.89 | DPP7 (0.48) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL10537153 | 0.89 | DPP7 (0.48) | DPP7CTSCCYP3A4CYP2D6CYP1A2 | |
| SCHEMBL6401404 | 0.89 | DPP7 (0.48) | DPP7CTSCCYP3A4CYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12543727-B2 | Thawing fluid, preparation method therefor and use thereof | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2026-02-10 | — | — | US | claimed |
| EP-4665372-A1 | NEW MULTI-FUNCTIONAL OLIGOPEPTIDES | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2025-12-24 | — | — | EP | claimed |
| US-12408659-B2 | DMSO-free cryopreservation solution and preparation method and use thereof | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2025-09-09 | — | — | US | claimed |
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| CN-120148690-A | Preparation method and application of fermented soybean containing bioactive peptide | 澳门科技大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119716028-A | Blood marker combination for distinguishing lung non-cancer diseases and early lung cancer, and screening method and application thereof | 哈尔滨脉图精准技术有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119591674-A | Cyclohexapeptide and preparation method and application thereof | 陕西未来多肽生物科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| US-20250066417-A9 | NEW PEPTIDE-BASED DIAGNOSTIC AND THERAPEUTIC AGENTS | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. (CN) | 2025-02-27 | — | — | US | claimed |
| CN-118979012-A | Thawing liquid for ovum or embryo and preparation method and thawing method thereof | 上海北里永幸医疗器械有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-118501300-B | Method for detecting total content of proline or hydroxyproline dipeptide in collagen peptide | 中国海洋大学三亚海洋研究院 | 2024-10-11 | — | — | CN | claimed |
| CN-111789102-B | Application of thawing solution in thawing frozen and preserved oocyte or embryo | 北京大学第三医院 | 2022-07-12 | — | — | CN | claimed |
| US-20220192180-A1 | THAWING FLUID, PREPARATION METHOD THEREFOR AND USE THEREOF | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2022-06-23 | — | — | US | claimed |
| US-20220167610-A1 | DMSO-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND USE THEREOF | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2022-06-02 | — | — | US | claimed |
| CN-111793109-B | Peptide compound and cryopreservation liquid containing same | 中国科学院化学研究所 | 2022-05-27 | — | — | CN | claimed |
| CN-111793108-B | Application of cryopreservation liquid containing peptide compounds in organ and tissue cryopreservation | 北京大学第三医院（北京大学第三临床医学院） | 2022-05-27 | — | — | CN | claimed |
| CN-111789103-B | Thawing solution for cryopreservation and thawing method | 中国科学院化学研究所 | 2022-05-27 | — | — | CN | claimed |
| US-20220142148-A1 | SERUM-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND APPLICATION THEREOF | INSTITUTE OF CHEMISTRY, CHINESE ACADEMIC OF SCIENCES (CN) | 2022-05-12 | — | — | US | claimed |
| CN-111793107-B | DMSO-free cryopreservation liquid and preparation method thereof | 中国科学院化学研究所 | 2022-04-12 | — | — | CN | claimed |
| US-20220105050-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2022-04-07 | — | — | US | claimed |
| US-20220057409-A1 | COMBINATORIAL TEMPORAL BIOMARKERS AND PRECISION MEDICINES WITH DETECTION AND TREATMENT METHODS FOR USE IN NEURO INJURY, NEURO DISEASE, AND NEURO REPAIR | GRYPHON BIO, INC. (US) | 2022-02-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12543727-B2 | Thawing fluid, preparation method therefor and use thereof | PCMT1, ARGLU1, TTR | DPP7 870/4885CTSC 742/4885CYP3A4 4462/4885 |
| US-20220142148-A1 | SERUM-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND APPLICATION THEREOF | BCL2L1, BCL2, BCL2L11 | DPP7 3307/4885CTSC 4139/4885CYP3A4 3708/4885 |
| US-20250066417-A9 | NEW PEPTIDE-BASED DIAGNOSTIC AND THERAPEUTIC AGENTS | NGLY1, YBX1, VIP | DPP7 1478/4885CTSC 720/4885CYP3A4 4678/4885 |
| US-12408659-B2 | DMSO-free cryopreservation solution and preparation method and use thereof | BCL2, BCL2L1, BCL2L2 | DPP7 1716/4885CTSC 2613/4885CYP3A4 3261/4885 |
| US-12377110-B2 | Fospropofol methods and compositions | FOS, FOSB, PFAS | DPP7 2007/4885CTSC 2217/4885CYP3A4 37/4885 |
| US-20220167610-A1 | DMSO-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND USE THEREOF | BCL2, BCL2L1, BCL2L2 | DPP7 1716/4885CTSC 2613/4885CYP3A4 3261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.